Global Lung Cancer Coalition Honors FairWarning’s Bridget Huber with 2013 Journalism Award
FOR IMMEDIATE RELEASE:
November 15, 2013
(Alexandria, Va.)—The Global Lung Cancer Coalition (GLCC) has selected FairWarning’s Bridget Huber as the recipient of this year’s 2013 Journalism Award for her piece “Stigma of ‘Smokers’ Disease’ Stifles Fight Against No. 1 Killer, Lung Cancer”. First runner up is Charlotte Huff, for her Slate article, “A Sick Stigma: Why are cancer patients blamed for their illness?”
The Lung Cancer Journalism Awards were first launched by the GLCC in May 2006 to recognize exceptional journalists who have raised awareness about lung cancer, a disease that receives very little media coverage in comparison with other types of cancer. Past recipients include CBS News’ Katie Couric and Boston’s Sports Radio WEEI 93.7.
Huber’s piece illustrates the lack of public awareness and research dollars for lung cancer, the number one cancer killer of both men and women in the U.S. Huber also highlights the stigma around the disease, as well as its accelerated progression compared to other types of cancer.
“Bridget has written an outstanding piece that brings to light many of the major issues surrounding lung cancer,” said GLCC Founding Member and President and Founder of the Prevent Cancer Foundation Carolyn “Bo” Aldigé. “The GLCC commends her exceptional work in highlighting this extremely underrepresented disease.”
Gregory Sorensen, M.D., chief executive officer, Siemens Healthcare North America and Laurie Fenton Ambrose, President and CEO, Lung Cancer Alliance were also honored with a Special Recognition award for non-journalists for their piece “Ending the Stigma,” featured in the Huffington Post.
The Global Lung Cancer Coalition consists of organizations from 21 countries in North America, South America, Europe, Asia and Australia. The Prevent Cancer Foundation, CancerCare, the National Lung Cancer Partnership, and Lung Cancer Alliance are the four U.S.-based GLCC organizations. The GLCC members work together and with partner organizations abroad to promote global understanding of the burden of lung cancer and the right of patients to effective early detection, better treatment and supportive care.
ABOUT THE GLOBAL LUNG CANCER COALITION (GLCC):
Created in 2001, the Global Lung Cancer Coalition (GLCC) is an international group of patient organizations dedicated to supporting the needs of lung cancer patients. The GLCC is also the first truly international patient alliance to promote global understanding of the burden of lung cancer and the rights of patients to effective early detection, better treatment and supportive care. By serving as the international voice of lung cancer patients, the GLCC is committed to improving disease outcomes for all.